Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Róbert Wessman

Tracked across 4 events · 26 articles · First seen Apr 30, 2026 · Last active Aug 21, 2026

Sentiment
15
Attention
4
Events
4
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 10
Business
Impact: Róbert Wessman, Founder and Executive Chairman of Alvogen, will be participating in the investor conferences, representing the company's leadership and strategic vision. His presence is crucial for conveying confidence and direction to investors.
Jun 02, 2026 · 6 articles
4 50
Business
Impact: Róbert Wessman, founder and chairman of Alvogen, expressed confidence in the financing's ability to provide flexibility and support the company's growth.
Jul 01, 2026 · 7 articles
2 0
Regulatory
Impact: Founder of Alvogen; mentioned in background but not directly involved in this event.
Jul 29, 2026 · 7 articles
4 0
Business
On August 21, 2026, Alvogen announced a strategic licensing and commercialization agreement with Rhythm Pharmaceuticals covering two biosimilar candidates: AVT34 (proposed biosimilar to Imfinzi/durvalumab) and AVT87 (proposed biosimilar to Hemlibra/emicizumab). Under the semi-exclusive U.S. agreement,…
Impact: Róbert Wessman is the founder of Alvogen, but he is not directly involved in this agreement.
Aug 21, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Róbert Wessman live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.